普莱柯：获得氟雷拉纳咀嚼片新兽药注册证书

Core Viewpoint - The approval of "Fluralaner Chewable Tablets" as a new veterinary drug by the Ministry of Agriculture and Rural Affairs marks a significant development for the company and its wholly-owned subsidiary, Luoyang Huizhong Veterinary Medicine Co., Ltd. [1] Group 1: Product Approval - The "Fluralaner Chewable Tablets" have been approved for the treatment of ectoparasite infections in dogs, specifically targeting ticks (Rhipicephalus sanguineus) and fleas (Ctenocephalides felis, Ctenocephalides canis) [1] - The product can be utilized as part of a treatment plan for flea allergy dermatitis [1] Group 2: Market Context - Currently, the company has not been able to find information regarding the sales status and market share of similar products available in the market through public channels [1]